Literature DB >> 28105345

Attenuation by incretins of thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.

Shingo Kainuma1, Haruhiko Tokuda2, Kazuhiko Fujita1, Tetsu Kawabata1, Go Sakai1, Rie Matsushima-Nishiwaki3, Atsushi Harada4, Osamu Kozawa3, Takanobu Otsuka5.   

Abstract

Incretins, the polypeptide hormone glucose- dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secreted from the small intestine after nutrient ingestion, are generally known to stimulate insulin secretion from pancreatic β-cells. We previously demonstrated that triiodothyronine (T3) stimulates osteocalcin synthesis at least in part through p38 mitogen-activated protein kinase in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the effects of GIP and GLP-1 on T3-stimulated osteocalcin synthesis and the mechanism of action involved in MC3T3-E1 cells. GIP and GLP-1 markedly suppressed the T3-stimulated osteocalcin release. GIP and GLP-1 significantly attenuated the expression levels of osteocalcin mRNA induced by T3. The T3-stimulated transactivation activity of the thyroid hormone-responsive element was reduced by GIP and GLP-1. These results suggest that incretins repressed the T3-stimulated osteocalcin synthesis in osteoblast-like MC3T3-E1 cells, and the suppressive effect of incretins was mediated through transcriptional levels.

Entities:  

Keywords:  glucagon-like peptide-1; glucose-dependent insulinotropic peptide; incretin; osteoblast; osteocalcin; triiodothyronine

Year:  2016        PMID: 28105345      PMCID: PMC5228533          DOI: 10.3892/br.2016.798

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  25 in total

1.  Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): a possible mechanism of hyperalkaline phosphatasia in hyperthyroidism.

Authors:  K Kasono; K Sato; D C Han; Y Fujii; T Tsushima; K Shizume
Journal:  Bone Miner       Date:  1988-09

2.  Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.

Authors:  R J Bollag; Q Zhong; K H Ding; P Phillips; L Zhong; F Qin; J Cranford; A L Mulloy; R Cameron; C M Isales
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

3.  Safety of Anti-Diabetic Therapies on Bone.

Authors:  Beata Lecka-Czernik
Journal:  Clin Rev Bone Miner Metab       Date:  2012-02-07

4.  Adenylyl cyclase-cAMP system inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.

Authors:  Yosuke Kanno; Akira Ishisaki; Minoru Yoshida; Keiichi Nakajima; Haruhiko Tokuda; Osamu Numata; Osamu Kozawa
Journal:  Mol Cell Endocrinol       Date:  2005-01-14       Impact factor: 4.102

Review 5.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

Review 6.  Biology of incretins: GLP-1 and GIP.

Authors:  Laurie L Baggio; Daniel J Drucker
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

Review 7.  The physiology of glucagon-like peptide 1.

Authors:  Jens Juul Holst
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

8.  Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow.

Authors:  C Sanz; P Vázquez; C Blázquez; P A Barrio; M Del M Alvarez; E Blázquez
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-29       Impact factor: 4.310

Review 9.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 10.  The contribution of bone to whole-organism physiology.

Authors:  Gérard Karsenty; Mathieu Ferron
Journal:  Nature       Date:  2012-01-18       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.